what is INVOKANA®?

pill

INVOKANA® is proven to lower blood sugar (A1C).

Used along with diet and exercise, INVOKANA® is the first in the newest class of diabetes medicines that's proven to significantly lower A1C in adults with type 2 diabetes.

clock

INVOKANA® is a once-daily pill that works around the clock.

reduction

The 300-mg dose of INVOKANA® is proven to show greater A1C reductions than Januvia® (sitagliptin).

Januvia® is a registered trademark of Merck Sharp & Dohme Corp.

INVOKANA® is not for weight loss, but may help you lose weight—on average 3%.

Results may vary by dose and
 when used with certain other diabetes medications.

blood preasure

Although it’s not a blood pressure medicine, you may see lower systolic blood pressure with INVOKANA®.

Results may vary by dose and
 when used with certain other diabetes medications.

a1c

In most clinical trials, the majority of people taking INVOKANA® reached an A1C goal of less than 7%.

As recommended by the American Diabetes Association.

check-mark

The most common side effects of INVOKANA® include genital yeast infections, urinary tract infections, and changes in urination.

Talk to your doctor about whether INVOKANA® may be right for you.

Indication and Important Safety Information

get more info

get more information

Interested in INVOKANA®? Register for more information.

save on medications

$0 co-pay every month

For most privately insured patients. Restrictions apply.

ongoing support

ongoing support

Janssen CarePath for INVOKANA® has free support for type 2 diabetes.